May 24 (Reuters) - Cyclopharm Ltd (CYC) :
- TECHNEGAS SHOWN TO HAVE A KEY ROLE IN DIAGNOSIS AND MANAGEMENT OF COVID-19
- FINDINGS INCLUDED ROLE OF TECHNEGAS IN DIAGNOSIS & ONGOING MANAGEMENT OF LONG COVID SYMPTOMS
News: CYC Cyclopharm Says Technegas Shown To Have Key Role In COVID-19 Diagnosis & Management
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.000(0.00%) |
Mkt cap ! $156.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9588 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 2800 | 1 |
View Market Depth
| Last trade - 16.12pm 06/11/2024 (20 minute delay) ? |
| CYC (ASX) Chart |
Day chart unavailable